Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
new york
new york blog main
new york top stories
agios pharmaceuticals
akcea therapeutics
anylam pharmaceuticals
biotech
cancer
cancer drugs
cardiomyopathy
david e. shaw
drug discovery
drugs
enasidenib
fda
inotersen
investing
ipo
ivosidenib
materials science
morphic
national top stories
neuropathy
nimbus therapeutics
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
sanofi
schrödinger
software
tafamidis
takeda pharmaceutical
tegsedi
What
medicines
2
×
sets
2
×
ago
akcea
alnylam
amyloidosis
approved
attr
available
battle
company’s
course
debilitating
development
discover
disease
drug
experimental
fda
genetic
growing
handiwork
helped
internal
ipo
landscape
oks
patients
pfizer
pipeline
rare
scan
schrödinger
schrödinger’s
software
spot
support
today
transthyretin
year
Language
unset
Current search:
sets
×
medicines
×
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea